← All indications
Neuritis
A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.
Subtype terms (2)
More specific conditions that are subtypes of Neuritis in the MeSH hierarchy.
- Brachial Plexus Neuritis
4 drugs approved
- Neuritis, Autoimmune, Experimental
Drugs by status
Phase 4 trials (4)
Phase 2 trials (9)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (16)
- Acorda Therapeutics
- Baxalta
- Nihon Pharmaceutical Co., Ltd
- Teva
- National Eye Institute (NEI)
- University of Copenhagen
- University of Ulsan
- University of Freiburg
- MedDay Pharmaceuticals
- Hopital Maison Blanche
- Roosevelt Hospital
- Humboldt University
- Washington University in St. Louis
- NeuroCure Clinical Research Center
- German Federal Ministry of Education and Research
- Alpharma
Organization Involved with Phase 2 Indications (28)
- CSL Behring
- Merck Serono
- Merck KGaA
- Sanofi
- Novartis
- Aarhus University
- University of London
- Guangxi Medical University
- Hacettepe University
- Hillel Yaffe Medical Center
- Thomas Jefferson University
- University of Milan
- University of Sydney
- University of Toronto
- University of Bern
- Saarland University
- University of Calgary
- University of California, San Francisco
- University of Vienna
- University of Haifa
- Isfahan University
- University of Oxford
- Technion University
- University of Goettingen
- National Multiple Sclerosis Society
- Multiple Sclerosis Society of Great Britain and Northern Ireland
- Neuroscience Canada
- Clene Nanomedicine
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (5)